Introduction {#s1}
============

Aging is a complex process in which cells gradually lose their ability to execute regular functions and organs show increased susceptibility to disease ([@bib18]). The causes of aging have been attributed to nine hallmarks ([@bib29]). However, crosstalk between these hallmarks is rare. Calorie restriction (CR) is the most effective intervention known to extend lifespan ([@bib31]), improve organism function, and retard cell senescence in a variety of species from yeast to mammals ([@bib31]; [@bib9]; [@bib8]; [@bib24]). CR delays the onset and/or reduces the incidence of many age-related diseases, including cancer, diabetes, and cardiovascular disorders ([@bib30]; [@bib46]).

Budding yeast has been perceived as an advantageous model to conveniently examine and isolate new components in aging-related pathways. In yeast, CR can be modeled by reducing the glucose concentration of the media from 2% as the *ad libitum* concentration to 0.5% (or lower), resulting in a 30--40% increase in lifespan ([@bib24]; [@bib23]). Two different lifespan paradigms are established in querying the lifespan of yeast cells: the replicative lifespan ([@bib54]) and chronological lifespan (CLS). RLS denotes the number of daughter cells that a single mother cell can generate before senescence, representing the division potential of the mother cell ([@bib35]), whereas CLS refers to the length of time for which yeast cells remain viable in a non-dividing state ([@bib27]).

CR exerts anti-aging effects by regulating metabolism ([@bib20]) and enhancing stress resistance ([@bib13]). These processes down-regulate the amino acid-sensing mTOR and the glucose-sensing PKA signaling pathways ([@bib63]). Attenuation of Tor1, Sch9, and PKA kinases promotes activation of Rim15 kinase-mediated transcription factors Msn2/4 and Gis1 to increase pathways in glycogen accumulation, antioxidant enzyme formation, heat shock protein expression, and autophagy ([@bib14]). Moreover, CR-mediated Tor1 repression enhances Snf1 kinase (the mammalian AMP kinase homologue in yeast) ([@bib39]) to extend CLS by promoting respiration, acetyl-CoA levels, and autophagy ([@bib25]; [@bib64]; [@bib59]; [@bib66]). Although these signaling pathways regulated by CR-modulated phosphorylation have been studied thoroughly, we speculate that there are other unknown regulators remaining to be explored. Here, we developed a screening procedure to discover additional pathways regulated under CR.

Results {#s2}
=======

A phosphoproteomic screening method identified Ids2 dephosphorylation under CR {#s2-1}
------------------------------------------------------------------------------

To explore anti-aging mechanisms, we performed mass spectrometry-based quantitative phosphoproteomic profiling to globally define the phosphorylation and dephosphorylation sites of regulated proteins under CR. The triplicate phosphoproteome maps generated from each calorie-restricted or normal glucose-treated sample were annotated with the phosphopeptides of unambiguously identified phosphorylated amino acid sequences ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Over 2672 unique phosphopeptides on 949 proteins were identified (p \< 0.05, [Figure 1](#fig1){ref-type="fig"}--source file 1). The rightward shift in the 2% glucose/0.5% glucose ratio of phosphopeptides in [Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"} indicated that the abundance of phosphopeptides decreased under 0.5% glucose, which is in agreement with that many kinases, such as Tor, Sch9, and PKA, were downregulated under CR ([@bib63]). Among these phosphopeptides, 318 proteins (508 phosphopeptides) showed a 2-fold increase under 0.5% glucose, meaning that these peptides were phosphorylated under a glucose-limited CR environment; 427 proteins (825 phosphopeptides) showed a 2-fold decrease under 0.5% glucose, indicating that these peptides were phosphorylated under a glucose-enriched environment; and 113 proteins contained both increased and decreased phosphopeptides on the same protein under 0.5% glucose.

![Ids2-S148 phosphorylation influences stress tolerance, growth, and chronological lifespan.\
(**A**) A schematic diagram highlights the steps in candidate screening. (**B**) Growth curves at 30°C were monitored in triplicate and represented as the mean ±S.E. (standard errors). (**C**) Tenfold serially diluted cells were grown under heat shock (37°C) in 2% glucose or at 30°C in 3% glycerol. WT and S148D mutants were compared using Student's t-test. \*, p \< 0.05. \*\*, p \< 0.01. (**D**) For the chronological lifespan assay, CFU viability was determined. 10-fold serial dilutions were spotted on YEPD plates. Quantitative CLS assay was assessed in triplicate by colony-forming capacity on YEPD plates.\
10.7554/eLife.39925.005Figure 1---source data 1.The list of total phosphopeptides influenced by calorie restriction.\
10.7554/eLife.39925.006Figure 1---source data 2.Genes and mutation sites for functional screening.](elife-39925-fig1){#fig1}

To discover additional pathways regulated by phosphorylation under CR, we designed an in silico and functional screening procedure ([Figure 1A](#fig1){ref-type="fig"}). [@bib18] total of 632 proteins quantified with 2-fold differential phosphorylation to Gene Ontology (GO) analysis ([@bib33]). Among them, 334 phosphoproteins were annotated to participate in biological processes including glycolysis (p \< 0.01), cytokinesis (p \< 0.01), signal transduction (p \< 1.0 × 10^−3^), cell communication (p \< 1.0 × 10^−3^), transcription (p \< 1.0 × 10^−5^), and stress response (p \< 1.0 × 10^−4^) ([Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}). Many instances of phosphorylation regulation in our database coincided with the existing CR/nutrient-sensing pathways ([@bib11]), such as PKA, Tor, and Snf1 ([@bib63]) ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}). In previous studies, CR has been shown to extend lifespan through an increase in respiration ([@bib24]), augmentation of cellular protection ([@bib63]), and induction of autophagy ([@bib34]). Thus, we challenged the deletion strains of 135 candidates in the top categories of the GO analysis with various stresses, including heat shock, oxidative stress, DNA replicative stress, and/or nonfermentable carbon growth. We also verified the efficiency of autophagy by a GFP-Atg8 cleavage assay ([@bib6]). Phenotypic analyses exhibited that 53 deletion strains showed defective phenotypes ([Figure 1---source data 2](#fig1sdata2){ref-type="supplementary-material"} and [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Phosphomimetic and/or dephosphomimetic mutations of these 53 candidates were generated to verify the functions observed in the deletion strains, and only the *ids2-S148D* phosphomimetic strain displayed a growth defect in heat shock and glycerol ([Figure 1B](#fig1){ref-type="fig"}). According to our mass spectrometry data ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}), S148 on Ids2 was identified (Ids2 RRS[S]{.ul}^148^IQDVQWIR) to be dephosphorylated under CR. The growth defect under CR was observed in *ids2Δ* and *ids2-S148D* cells ([Figure 1C](#fig1){ref-type="fig"}). Moreover, the *ids2-S148D* phosphomimetic strains showed shortened CLS ([Figure 1D](#fig1){ref-type="fig"}). Ids2 is involved in the modulation of Ime2 during meiosis ([@bib50]); however, it is a functionally unknown protein in the mitotic cell cycle. We, therefore, speculated that Ids2-S148 phosphorylation may play an important role in stress response and lifespan control.

PKA phosphorylates Ids2 upon glucose intake, and PP2C dephosphorylates Ids2 under CR {#s2-2}
------------------------------------------------------------------------------------

Because the protein level of Ids2 did not change under CR ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}), we hypothesized that the phosphorylation status of Ids2 may modulate its function. To verify the CR-mediated Ids2 phosphorylation, an antibody against S148 phosphorylation was generated ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). Western blot analysis showed that Ids2-S148 phosphorylation decreased under CR ([Figure 2A](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1D](#fig2s1){ref-type="fig"}) but not under nitrogen starvation or TOR pathway inhibition ([Figure 2B](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1D](#fig2s1){ref-type="fig"}). Based on the PhosphoGRID and pkaPS databases ([@bib37]), Ids2 RRS[S]{.ul}^148^IQD may be phosphorylated by PKA (score = 1.57). Deletion of one PKA catalytic subunit, *TPK3,* reduced the Ids2 phosphorylation significantly ([Figure 2C](#fig2){ref-type="fig"}), suggesting that Tpk3 may phosphorylate S148. Deletion of *RAS2* or *GPA2*, the two PKA upstream regulators did not affect Ids2 phosphorylation ([Figure 2---figure supplement 1E](#fig2s1){ref-type="fig"}), implying that they act in a redundant manner. An in vitro kinase assay demonstrated that GST-Ids2 was phosphorylated by wild-type PKA kinase from the extract of the KT1115 strain ([Figure 2D](#fig2){ref-type="fig"}) or by the bovine heart PKA catalytic subunit C ([Figure 2---figure supplement 1F](#fig2s1){ref-type="fig"}) but not by the extract of the PKA kinase-dead strain ([Figure 2D](#fig2){ref-type="fig"}). These results indicated that PKA may directly phosphorylate Ids2-S148.

![PKA and PP2C regulate Ids2-S148 phosphorylation.\
(**A--C, E**) Strains were transformed with pRS426-Ids2-Myc~13~, and lysates were examined by Western blot analysis with the indicated antibodies. The numbers below are the means of the intensity ratios of Ids2-p148/Myc compared with that of WT treated with 2% glucose. (**B**) Overnight cells were refreshed in medium with different treatments for 3 hr. (**D,F**) In vitro kinase and phosphatase assays were conducted as described in the Methods section. (**G**) Cells were spotted in 10-fold dilutions on YEPD or YEPG plates and grown at 30 or 37°C.](elife-39925-fig2){#fig2}

To determine the phosphatase(s) dephosphorylating Ids2-S148, we examined the phosphorylation levels in the mutants of major phosphatases. The Ids2 phosphorylation level increased in *ptc2Δ ptc3Δ* cells compared with that in the wild-type ([Figure 2E](#fig2){ref-type="fig"}). An in vitro phosphatase assay showed that recombinant Ptc2 removed the S148 phosphorylation ([Figure 2F](#fig2){ref-type="fig"}), indicating that PP2C may directly dephosphorylate Ids2. Moreover, a spotting assay showed that the *ids2-S148A* mutation could rescue the growth defect in the *ptc2Δ, ptc3Δ* and *ptc2Δ ptc3Δ* mutants ([Figure 2G](#fig2){ref-type="fig"}), suggesting that the PP2C phosphatases ([@bib49]) may dephosphorylate Ids2.

Ids2 interacts with chaperone HSP90 in a phosphorylation-modulated manner {#s2-3}
-------------------------------------------------------------------------

To understand the molecular mechanism that Ids2 participates in under CR, we searched for its interaction partners via tandem affinity purification (TAP) and mass spectrometry analysis ([@bib26]). The bead-bound proteins were separated ([Figure 3](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), and spectrometry analysis revealed two closely related proteins, Hsc82 and Hsp82 ([@bib48]), in the yeast HSP90 family ([Figure 3](#fig3){ref-type="fig"}--source file 1). Expression of Hsc82 is tenfold higher than that of Hsp82 under normal conditions, suggesting that Hsc82 plays a more prominent role ([@bib48]). The co-immunoprecipitation assay showed that Hsc82-HA~3~ co-precipitated with Ids2-Myc~13~ ([Figure 3B](#fig3){ref-type="fig"}). A yeast two-hybrid analysis revealed that amino acids 92--256 of Ids2 interact with amino acids 272--579 of Hsc82 ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Immunoprecipitation of Ids2*-*S148D with Hsc82 was significantly decreased, while the Ids2-S148A mutation increases the interaction with Hsc82 ([Figure 3C](#fig3){ref-type="fig"}). In addition, the phosphomimetic S148D mutation of purified recombinant Ids2 impaired the Ids2-Hsc82 interaction in the affinity pull-down assay ([Figure 3D](#fig3){ref-type="fig"}), suggesting that the phosphorylation of S148, which is located within the interacting motif (92-256), may inhibit the Ids2-Hsc82 interaction. To examine the interaction between Ids2 and Hsc82 under CR, an overnight culture was refreshed in medium with 2% or 0.5% glucose. As expected, CR significantly increased the Ids2-Hsc82 interaction ([Figure 3E](#fig3){ref-type="fig"}).

![Ids2 interacts with HSP90 families.\
(**A**) A silver-stained gel of the affinity-purified Ids2. Both HSP90 families, Hsc82 and Hsp82, were identified by LC-MS/MS analysis. (**B**) A co-immunoprecipitation assay was conducted using chromosomal-tagged Ids2-Myc~13~ and Hsc82-HA~3~. (**C**) Co-immunoprecipitation assay between Hsc82 and Ids2 mutants. The levels of signal compared with that of WT are shown below. (**D**) Purified recombinant GST-Ids2 and His~6~-Hsc82 proteins were subjected to a His-tagged Metal Affinity Purification assay. (**E**) Tagged strains were incubated in 2% (normal) or 0.5% ([@bib17]) glucose. Ids2-Myc~13~ was used to co-immunoprecipitate Hsc82-HA~3~. The numbers below are the means of the intensity ratios of HA/Myc compared with that of WT.\
10.7554/eLife.39925.012Figure 3---source data 1.A list of peptides detected from Mass Spectrometry analysis of the Ids2-TAP co-purified proteins.](elife-39925-fig3){#fig3}

Ids2 acts as a co-chaperone in the HSP90-mediated protein-folding process {#s2-4}
-------------------------------------------------------------------------

HSP90 is an essential eukaryotic chaperone with a well-established role in folding and maintenance of proteins that are associated with the cell signaling response, such as kinases and hormone receptors ([@bib48]). However, the active participation of co-chaperone proteins at various stages of the chaperone folding cycle is crucial for the completion of the folding process ([@bib22]). Due to the physical interaction between Ids2 and Hsc82, we speculated that Ids2 may function as either a substrate or a regulator of HSP90. Deletion of *HSC82* did not change the stability of Ids2, suggesting that Ids2 may not be a substrate of Hsc82 ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Many co-chaperones can regulate HSP90 ATPase, an activity essential for its chaperoning action ([@bib43]; [@bib65]). To test whether Ids2 could modulate the ATPase activity of Hsc82, we performed an Hsc82 ATPase assay with increasing concentration of Ids2 or Ids2-S148D. The assay revealed that Ids2 triggers ATPase activity of Hsc82 and phosphorylation of Ids2 attenuates the reaction ([Figure 4A](#fig4){ref-type="fig"}). Hsc82 is required for mitochondrial F1-ATPase assembly ([@bib15]). The *ids2Δ* and *ids2-S148D* strains displayed a growth defect in glycerol ([Figure 1C](#fig1){ref-type="fig"}), and formed white colonies ([Figure 4B](#fig4){ref-type="fig"}), which are caused by the loss of mitochondrial function in the W303-1A strain ([@bib60]), implying that the phosphorylation of Ids2 may hamper the Hsc82 chaperone activity and thereby diminish the mitochondrial function.

![Ids2 participates in the HSP90-regulated protein-folding response.\
(**A**) The purified Hsc82 was mixed with Ids2 or Ids2-S148D, and the ATPase reaction was incubated for 90 min at 37°C. Error bars represent the standard deviation (SD) calculated from three independent experiments. (**B**) Cells, as indicated, were streaked on SC glucose, and the plate image was captured after 3 days. (**C**) An in vivo chaperone assay was conducted using an exogenously expressed firefly luciferase, and Western blot analysis was performed. (**D**) Endogenously expressed Gln1-GFP in WT and mutant cells was measured after 45 min without glucose. At least 200 cells were counted for each strain (\*\*, p \< 0.01, Student's t-test, two-tailed). The mRNA levels of *GLN1* were determined by quantitative RT-PCR relative to the housekeeping gene, *ACT1*. Error bars represent SD for three biological replicates.](elife-39925-fig4){#fig4}

We next asked whether Ids2 acts as a co-chaperone of HSP90 in the establishment of the HSP90-mediated protein-folding process. A firefly luciferase reporter assay was used to determine the ability of HSP90-dependent protein refolding ([@bib12]). Western blot analysis revealed that the protein abundance of firefly luciferase was slightly reduced in *ids2Δ* cells compared to that in *hsc82Δ* cells at 30°C; however, luciferase expression was completely lost in *ids2-S148D* cells, while *ids2-S148A* cells expressed an amount of firefly luciferase equivalent to that of the wild-type ([Figure 4C](#fig4){ref-type="fig"}). Meanwhile, firefly luciferase could not be detected in the *ids2Δ* and *hsc82Δ* strains at 37°C. Since the accumulation of misfolded proteins would result in degradation ([@bib12]), a mutant HSP90 chaperone or a dissociation of the chaperone folding network could cause mass accumulation and subsequent degradation of HSP90-dependent substrates. To further investigate the influence of phosphorylated Ids2 on the chaperone function of Hsc82, we conducted the glucocorticoid receptor (GR) maturation ([@bib47]) and v-Src toxicity ([@bib53]; [@bib36]) assays. GR activities in the *ids2Δ* and *ids2-S148D* strains decreased about 30% compared with that in the wild-type cells ([Figure 4---figure supplement 2A](#fig4s2){ref-type="fig"}). Consistently, the v-Src toxicity, which is strictly dependent on yeast HSP90 in vivo ([@bib53]; [@bib36]), reduced in the *ids2Δ* and *ids2-S148D* strains ([Figure 4---figure supplement 2B](#fig4s2){ref-type="fig"}). Taken together, these findings further elucidate that Ids2 may act as a co-regulator for the chaperone activity of HSP90.

Protein aggregates are found in a variety of diseases, including type II diabetes, Parkinson's disease, and Alzheimer's disease ([@bib7]). In yeast, many cellular protein aggregates form during aging, for example, Gln1 aggregates with HSP90 upon glucose deprivation and cellular aging ([@bib38]). Thus, we speculated that compromising the function of Ids2 may lead to aggregation of Gln1. We examined the Gln1-GFP localization in *ids2* phosphomimetic mutants under glucose deprivation ([Figure 4D](#fig4){ref-type="fig"}). The number of Gln1 foci in *ids2-S148D* mutants was dramatically increased compared to that in wild-type and *ids2-S148A* strains, implying that Ids2 phosphorylation may trigger Gln1 aggregation through down-regulation of HSP90 activity.

To determine if dephosphorylation of Ids2 is important for CR-induced lifespan extension, the CLS of *ids2Δ, hsc82Δ*, *ids2-S148A* and *ids2-S148D* were examined under CR ([Figure 4---figure supplement 2C](#fig4s2){ref-type="fig"}). CLS of the *ids2-S148A* strains under CR prolonged to the same extent as that of the wild-type strain, while the *ids2-S148D* strains lost CR-mediated lifespan extension. Therefore, dephosphorylated Ids2 is critical for the extended lifespan under CR.

Discussion {#s3}
==========

Multiple approaches that integrate large genomic and proteomic datasets have facilitated the identification of factors governing longevity. However, crosstalk between these aging pathways is rare. Both nutrient sensing and proteostasis control lifespan. Here, our phosphoproteomic screen mapped 632 yeast proteins containing CR-responsive phosphorylation, although we could not rule out the possibility that some of the alterations might be due to a change in the abundance of the protein itself. Coupled with functional analyses, we identified a co-chaperone protein, Ids2, which is inactivated under glucose intake. The PKA writer and PP2C eraser may orchestrate glucose sensing and protein folding, and phosphorylation of Ids2 impedes its association with HSP90. Thus, glucose concentration may influence the HSP90 chaperone activity, enabling cells to control protein quality under environmental conditions for sustained longevity ([Figure 5](#fig5){ref-type="fig"}). Our findings are consistent with a previous large-scale analysis of the genetic interaction between HSP90 and Ids2 ([@bib16]). We predict that Ids2 is a key regulator in promoting cellular tolerance to stress. HSP90 is a conserved protein controlling late protein-folding steps. Interestingly, sequence alignments of Ids2 show a certain degree of sequence similarity across homologues of HSP90 co-chaperones ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}), including the S148 residue. It will be interesting to learn whether Ids2 homologues in other organisms also control lifespan.

![A proposed model to describe how glucose intake down-regulates chaperone activity and leads to aging.\
After glucose ingestion, cells convert ATP to cAMP to activate the PKA pathway. Activated PKA phosphorylates co-chaperone Ids2 to dissociate it from the HSP90 chaperone and reduce chaperone function, eventually leading to protein unfolding, mitochondrial dysfunction, and protein aggregation. However, under CR, dephosphorylated Ids2 might be essential for the full function of HSP90 to extend lifespan.](elife-39925-fig5){#fig5}

Two lines of observation demonstrated that glucose intake modulates HSP90: high-glucose consumption boosts rat HSP90 expression ([@bib67]) and PKA-mediated porcine HSP90α phosphorylation enhances the translocation of endothelial HSP90α to the cell surface ([@bib21]). Through this study, we discovered a previously underappreciated glucose-mediated chaperone regulatory process: glucose concentration modulates HSP90 activity by PKA-dependent co-chaperone phosphorylation. Other than glucose consumption, heat shock ([@bib57]) and oxidative stress ([@bib40]) have been shown to regulate the PKA pathway. Indeed, heat shock and oxidative stress both hamper Ids2 phosphorylation, suggesting that cells may use Ids2 dephosphorylation to stimulate chaperone activity for coping with various stresses.

We revealed that PP2C phosphatase antagonizes the function of PKA to extend lifespan. *S. cerevisiae* encodes seven phosphatases in the type 2C Ser/Thr phosphatase (PP2C) superfamily (Ptc1-Ptc7) ([@bib3]), and Ptc1, Ptc2, and Ptc3 are negative regulators of MAPK ([@bib62]). In deficiencies of the MAPK pathway, cells elevate their stress tolerance ability to extend CLS ([@bib2]). Although currently there is no direct evidence that PP2C may control stress tolerance through the MAPK pathway, our study provides a means by which PP2C governs stress tolerance: PP2C removes PKA-mediated Ids2 phosphorylation to maintain ample chaperone activity.

Finally, what is the role of Ids2 in protein folding at the molecular level? HSP90 forms a homodimeric complex, which consists of an N-terminal nucleotide-binding domain (NBD), a middle domain (M), and a C-terminal dimerization domain (CTD) ([@bib1]). Co-chaperones can bind to specific domains of HSP90 to stabilize its conformation and further modulate its function. For example, yeast Sti1/Hop and human FKBP51 and FKBP52 utilize their tetratricopeptide (TPR) domains to interact with the C-terminal EEVD motif of HSP90 ([@bib44]) to stabilize chaperones. Moreover, the N-terminal region of co-chaperone Aha1 interacts with the M domain of HSP90 to stabilize its closed state conformation and thereby increase its ATPase activity ([@bib32]). Our domain mapping results determined that Ids2 also binds to the M domain of HSP90 and stimulates the ATPase activity of HSP90. In addition, Ids2 forms complex with Aha1 in our MS/MS data of the Ids2-TAP complex. Thus, it will be of interest to investigate the different controlling mechanisms and client specificities of Ids2 and Aha1 in modulating HSP90. Much work will be required to understand the mechanistic role of co-chaperone Ids2.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\   Designation            Source or\       Identifiers                                                       Additional\
  (species) or\                          reference                                                                          information
  resource                                                                                                                  
  --------------- ---------------------- ---------------- ----------------------------------------------------------------- ----------------
  Antibody        anti-Myc\              Roche            11667149001;\                                                     (1:2000)
                  (mouse\                                 RRID: [AB_390912](https://scicrunch.org/resolver/AB_390912)       
                  monoclonal)                                                                                               

  Antibody        anti-HA\               Roche            11583816001;\                                                     (1:5000)
                  (12CA5) (mouse\                         RRID: [AB_514506](https://scicrunch.org/resolver/AB_514506)       
                  monoclonal)                                                                                               

  Antibody        anti-ACTIN\            Sigma-Aldrich    A2066;\                                                           (1:2000)
                  (rabbit\                                RRID:[AB_476693](https://scicrunch.org/resolver/AB_476693)        
                  polyclonal)                                                                                               

  Antibody        anti-Hsp90\            PMID: 23434373                                                                     (1:10000)
                  (rabbit\                                                                                                  
                  polyclonal)                                                                                               

  Antibody        anti-GST\              GeneTex          GTX110736;\                                                       (1:2000)
                  (rabbit\                                RRID: [AB_1949427](https://scicrunch.org/resolver/AB_1949427)     
                  polyclonal)                                                                                               

  Antibody        anti-Pgk1\             Invitrogen       459250                                                            (1:5000)
                  (mouse\                                                                                                   
                  monoclonal)                                                                                               

  Antibody        anti-(P)\              This paper                                                                         (1:1000)
                  S148-Ids2\                                                                                                
                  (rabbit purified\                                                                                         
                  polyclonal\                                                                                               
                  antibody)                                                                                                 

  Antibody        anti-Firefly\          GeneTex          GTX125849;\                                                       (1:5000)
                  Luciferase                              RRID: [AB_11173184](https://scicrunch.org/resolver/AB_11173184)   

  Commercial\     EnzChek\               Thermo Fisher\   E6646                                                             
  assay or kit    phosphate\             Scientific                                                                         
                  assay kit                                                                                                 

  Commercial\     KAPA SYBR\             Sigma-\          KK4600                                                            
  assay or kit    FAST\                  Aldrich                                                                            
                  qPCR Master\                                                                                              
                  Mix Kit                                                                                                   

  Other           Calmodulin\            GE\              17-0529-01                                                        Affinity resin
                  Sepharose 4B           Healthcare                                                                         

  Other           TALON\                 GE\              28-9574-99                                                        Affinity resin
                  Superflow              Healthcare                                                                         

  Other           IgG Sepharose\         Amersham\        17-0969-01                                                        Affinity resin
                  6 Fast Flow            Pharmacia\                                                                         
                                         Biotech AB                                                                         

  Other           Glutathione\           GE\              17-5132-01                                                        Affinity resin
                  Sepharose 4\           Healthcare                                                                         
                  Fast Flow                                                                                                 

  Chemical\       Deoxycorticosterone\   Sigma-\          D7000                                                             
  compound,\      acetate                Aldrich                                                                            
  drug                                                                                                                      

  Chemical\       Protease\              Roche            4693132001                                                        
  compound,\      inhibitor\                                                                                                
  drug            cocktail tablets                                                                                          

  Chemical\       PKA,\                  Millipore        539576                                                            
  compound,\      catalytic\                                                                                                
  drug            subunit,\                                                                                                 
                  bovine heart                                                                                              

  Software        Image J                                 RRID: [SCR_003070](https://scicrunch.org/resolver/SCR_003070)     Image\
                                                                                                                            analysis

  Software        GraphPad\                               RRID: [SCR_002798](https://scicrunch.org/resolver/SCR_002798)     Statistical\
                  Prism5                                                                                                    analysis\
                                                                                                                            and graph\
                                                                                                                            representation
  ------------------------------------------------------------------------------------------------------------------------------------------

Plasmids and yeast strains {#s4-1}
--------------------------

The yeast strains and plasmids used in this study are listed in [Supplementary file 1](#supp1){ref-type="supplementary-material"}. Standard genetic and cloning methods were used for all constructions. pYES2-Ids2-TAP was generated by ligation of a PCR product from the Ids2-TAP HISMX6 strain into the KpnI-XhoI-treated pYES2. Kanamycin-resistant knockout strains were constructed through the transformation of kanamycin selection cassette fragments derived from PCR of BY4741. pRS306-*ids2* and other yeast integrating plasmids were PCR-amplified and cloned into pRS306. Single-point or multiple-site mutations were introduced into pRS306-based plasmids by site-directed mutagenesis. The oligonucleotides designed for mutagenesis and double crossover are listed in S4 Data. To generate chromosomal mutants of these genes, the pRS306-based plasmids were linearized by the appropriate restriction enzymes and transformed into the wild-type strain. After confirming the pop-in structure by Southern blot analysis and 5-FOA selection, the *URA3* pop-out mutants were selected and verified by PCR and sequencing. The C-terminal-tagged Gln1 was created by insertion of the PCR products of the GFP-*HIS3* cassette.

Sample preparation for phosphopeptide enrichment {#s4-2}
------------------------------------------------

Yeast cells were grown in yeast extract peptone dextrose (YPD) medium (1% yeast extract, 2% bacto-peptone) supplemented with 2% (normal condition) or 0.5% glucose (calorie-restricted) for 3 hr and then harvested from log-phase growing cultures. Protein samples were extracted and subjected to gel-assisted digestion ([@bib61]). First, proteins were fixed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS*-*PAGE) directly, and the gel was cut into five pieces for trypsin proteolytic digestion. Digested peptides were extracted three times for 30 mins each and completely dried by vacuum centrifugation at room temperature. Then, we used a homemade immobilized metal affinity column for phosphopeptide enrichment ([@bib19]). An Ultra-Performance LC^TM^ system (Waters) was used for automated purification of phosphopeptides. The Ni^2+^ ions were removed, and the nitrilotriacetic acid resin was activated. The peptide samples from trypsin digestion were re-established in loading buffer and loaded into an activated immobilized metal affinity chromatography column. Finally, the unbound peptides were removed, and the bound peptides were eluted.

LC-MS/MS Analysis {#s4-3}
-----------------

The purified phosphopeptides were analyzed in triplicate LC-MS/MS by an LTQ-Orbitrap XL hybrid mass spectrometer interfaced with an Agilent 1100 series HPLC. Survey full-scan MS spectra were acquired in the Orbitrap (*m*/*z* 350--1600) with the resolution set to 60,000 at *m*/*z* 400 and the automatic gain control target at 106. The 10 most intense ions were sequentially isolated for an MS/MS scan using collision-induced dissociation and detection in the linear ion trap with previously selected ions and dynamic exclusion for 90 s. All the measurements in the Orbitrap were performed with the lock mass option for internal calibration. Raw MS/MS data from the LTQ-Orbitrap were transformed to msm files using RAW2MSM software (version 1.1). The msm files were searched using Mascot (version 2.2.1) against the Swiss-Prot *Saccharomyces cerevisiae* database (version 54.2, 6493 sequences) with the following exceptions: only tryptic peptides with up to two missed cleavage sites were allowed, the fragment ion mass tolerance was set at 10 ppm, and the parent ion tolerance was set at 0.6 Da. Phosphorylation ([@bib41]) and oxidation (M) were specified as variable modifications. Peptides were considered identified if their Mascot individual ion score was greater than 20 (*p*-0.05). The false discovery rates for Orbitrap data were determined with a Mascot score greater than 20 (*p*-0.05). The quantitative analysis of phosphopeptides was performed with the SEMI label-free algorithm ([@bib45]). The raw data files acquired from the LTQ-Orbitrap were converted into files of the mzXML format by the program ReAdW, and the search results in MASCOT were exported in Extensible Markup Language data (.xml) format. After data conversion, the confident peptide identification results (*p*-0.05) from each LC-MS/MS run were loaded and merged to establish a global peptide information list (sequence, elution time, and mass-to-charge ratio). Alignment of elution time was then performed based on the peptide information list using linear regression in different LC-MS/MS runs followed by correction of aberrational chromatographic shifts across fragmental elution-time domains. The mass spectrometry raw datasets were deposited to the ProteomeXchange Consortium ([@bib58][; http://proteomecentral.proteomexchange.org](http://proteomecentral.proteomexchange.org)) dataset identifier PXD001368 and DOI 10.6019/PXD001368. The quantitation results for phosphopeptides listed in S1 Data were obtained using IDEAL-Q software and further checked manually ([@bib4]).

Bioinformatics analysis - Gene Ontology enrichment analysis and KEGG orthology analysis {#s4-4}
---------------------------------------------------------------------------------------

To functionally define the genes identified in this study, we performed Gene Ontology (GO), network, and pathway analyses using the PANTHER classification system ([@bib33][; http://www.pantherdb.org/](http://www.pantherdb.org/)). The genes showing a 2-fold change with Bonferroni multiple correction testing were annotated for GO terms. The spatial-compartmental relationship and the genome annotation between the phosphopeptides were defined through the use of KEGG (Kyoto Encyclopedia of Genes and Genomes) orthology, a genomic, biochemical and enzyme-substrate metabolism-based online database developed by the team of Minoru Kanehisa of Kyoto University ([@bib10]).

Stress resistance assay {#s4-5}
-----------------------

Yeast cells were first grown overnight in yeast extract peptone (YEP) or synthetic complete ([@bib58]) glucose medium at 30°C. Then, cells were re-inoculated into fresh YEP or SC medium and grown to exponential phase (OD~600~ = 0.5). Tenfold serial dilutions of indicated strains were spotted onto YEP with 2% glucose (YEPD), YEP with 3% glycerol (YEPG), or SC glucose plates containing various concentrations of chemicals: 0.04% Methyl methanesulfonate (MMS), 100 mM hydroxyurea, 10 mM H~2~O~2~, 400 mM LiCl, 50 µg/ml hygromycin B (Hyg B), and 5 nM rapamycin, and incubated at 30°C (normal) or 37°C (heat shock) for 2--3 days.

Chronological lifespan assay {#s4-6}
----------------------------

The CLS assay of wild-type, *ids2Δ*, *ids2-S148A,* and *ids2-S148D* strains were carried out as previously described ([@bib42]; [@bib28]). Viability at day 3, when the yeast had reached stationary phase, was defined as the point of 100% survival. Thereafter, aliquots from the culture were diluted according to the estimated survival and plated on YEPD plates every other day. After 3 days of incubation at 30°C, colony-forming units were calculated. A semi-quantitative CLS spotting assay was also performed as previously described ([@bib52]). In brief, the same cell numbers from the culture were serially diluted 10-fold and spotted on YEPD plates every 2 days.

Tandem Affinity Purification {#s4-7}
----------------------------

Tandem affinity purification of Ids2 was performed as previously described ([@bib56]) in the protocol from the Yeast Resource Center of the University of Washington. In brief, the BJ2168 pYES2-Ids2-TAP strain was inoculated into one liter SC with 2% raffinose and grown to log phase prior to adding galactose to induce protein overexpression. Cells were lysed with lysis buffer (150 mM NaCl, 1% Nonidet P-40, 50 mM Tris-HCl pH 7.5, and protease inhibitors) and with the use of glass beads and a homogenizer. Then, 250 µL of IgG Sepharose 6 Fast Flow prep in 1:1 slurry in NP-40 was added to the lysate and incubated at 4°C for 2 hr with gentle shaking. Beads were washed three times with lysis buffer and once with TEV cleavage buffer. Fifty units of TEV protease (Thermos) was added, and the solution was incubated overnight. The supernatant was collected, and calmodulin-binding buffer (25 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM Mg acetate, 1 mM imidazole, 2 mM CaCl~2~, 10 mM β-mercaptoethanol, 0.1 % NP-40) and 200 µL of calmodulin sepharose beads (GE Healthcare) were added for a 2 hr incubation at 4°C. Samples were washed, and the bound proteins were eluted into fractions with calmodulin elution buffer (25 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM Mg acetate, 1 mM imidazole, 20 mM EGTA, 10 mM β-mercaptoethanol, 0.1 % NP-40). The eluents were combined and precipitated with 25% trichloroacetic acid. The samples were analyzed with 10% SDS-PAGE gels and stained with silver stain. Bands were cut out and trypsinized for mass spectrometry analysis.

One-dimensional SDS-PAGE combined nano-LC-MS/MS (GeLC-MS/MS) {#s4-8}
------------------------------------------------------------

To identify the Ids2-TAP interacting proteins, GeLC-MS/MS, one of the targeted proteomics approaches, was applied as described previously ([@bib26]). Briefly, gel pieces were destained in 50 mM NH~4~HCO~3~/ACN (3:2, v/v) three times for 25 min each, dehydrated in ACN and dried in a SpeedVac. In-gel proteins were reduced with 10 mM dithiothreitol in 25 mM NH~4~HCO~3~ at 56°C for 45 min, allowed to stand at room temperature (RT) for 10 min, and then alkylated with 55 mM iodoacetamide in the dark for 30 min at RT. After the proteins were digested by sequencing grade modified porcine trypsin (1:100; Promega, Madison, WI) overnight at 37°C, peptides were extracted from the gel with ACN to a final concentration of 50%, dried in a SpeedVac, and then stored at 20°C for further use. For reverse-phase LC-MS/MS analysis, each peptide mixture was resuspended in HPLC buffer A (0.1% formic acid, Sigma, St. Louis, MO) and loaded into a trap column (Zorbax 300 SB-~C18~, 0.3 × 5 mm, Agilent Technologies, Wilmington, DE) at a flow rate of 0.2 μL/min in HPLC buffer A. The salts were washed with buffer A at a flow rate of 20 μL/min for 10 min, and the desalted peptides were then separated on a 10 cm analytical C~18~ column (inner diameter, 75 μm). The peptides were eluted by a linear gradient of 0--10% HPLC buffer B (99.9% ACN containing 0.1% formic acid) for 3 min, 10--30% buffer B for 35 min, 30--35% buffer B for 4 min, 35--50% buffer B for 1 min, 50--95% buffer B for 1 min, and 95% buffer B for 8 min at a flow rate of 0.25 μL/min across the analytical column. The LC setup was coupled online to an LTQ-Orbitrap linear ion trap mass spectrometer (Thermo Scientific, San Jose, CA) operated using Xcalibur 2.0.7 software (Thermo Scientific). Full-scan MS was performed using the Orbitrap in an MS range of 400--2000 Da, and the intact peptides were detected at a resolution of 30,000. Internal calibration was performed using the ion signal of cyclosiloxane peaks at m/z 536.165365 as a lock mass. A data-dependent procedure was applied that alternated between one MS survey scan and six MS/MS scans for the six most abundant precursor ions in the MS survey scan with a 2 Da window and fragmentation via CID with 35% normalized collision energy. The electrospray voltage applied was 1.8 kV. Both MS and MS/MS spectra were acquired using one microscan with a maximum fill-time of 1000 and 150 ms for MS analysis, respectively. Automatic gain control was used to prevent overfilling of the ion trap, and 5 × 10^4^ ions were accumulated in the ion trap to generate the MS/MS spectra. All the MS and MS/MS data were analyzed and processed using Proteome Discoverer (version 1.4, Thermo Scientific). The top six fragment ions per 100 Da of each MS/MS spectrum were extracted for a protein database search using the Mascot search engine (version 2.4, Matrix Science) against the UniProtKB/Swiss-Prot sequence database. The top-six-peaks filter node improved the number of peptides identified with high confidence by reducing the number of peaks in the searched peak lists. This method avoids matching peptide candidates to spurious or noise peaks, thereby avoiding false peptide matches. The search parameters were set as follows: carbamidomethylation (C) as the fixed modification, oxidation (M), N-acetyl (protein), pyro-Glu/Gln (N-term Q), six ppm for MS tolerance, 0.8 Da for MS/MS tolerance, and two for missing cleavage. After database searching, the following filter criteria were applied to all the results: a minimum peptide length of six, a minimum of two unique peptides for the assigned protein, and peptide and protein identification with FDR less than 1% peptide filter were accepted. For precursor ion quantification, Proteome Discoverer was employed using a standard deviation of 2 ppm mass precision to create an extracted ion chromatogram (EIC) for the designated peptide.

Antibody generation and western blot analysis {#s4-9}
---------------------------------------------

Cells were grown at 30°C in YEPD medium. Cell lysates were prepared with lysis buffer (150 mM NaCl, 1% nonidet P-40, 1% deoxycholate, 0.1% SDS, 50 mM Tris-HCl, pH 7.5, and protease inhibitors) or precipitated with trichloroacetic acid. To generate antibodies, rabbits were boosted with carrier-conjugated phosphopeptides once per month. Pre-immune sera were collected before boosting. Blood was collected every 2 weeks, incubated at 37°C for 30 mins, and separated via high-speed centrifugation. Clarified serum was incubated at 56°C for 30 mins to remove complement. The specificity of antibodies was verified by means of peptide dot blot analysis. Images were captured and quantified by a bioluminescence imaging system (UVP BioSpectrum AC Imagine System, UVP).

In Vitro kinase and phosphatase assays {#s4-10}
--------------------------------------

The Ids2 ORF was cloned into the EcoRI and XhoI sites of pGEX-4T-1 for expression of GST-Ids2. A point mutation of Ids2-S148 was created to express GST-Ids2-S148A. Bovine heart catalytic subunit C (C~b~) was purchased from Millipore and PKI 6--22 (Millipore) was used as a negative control. PKA was obtained from crude extracts of yeast strain KT1115, and the PKA kinase-dead strain was used as a negative control ([@bib55]). For the phosphatase assay, the full-length Ptc2 and the C terminal-truncated Ptc2 (1-312) sequences were cloned into the BamHI and SalI sites of pGEX-4T-1 for the expression of GST-Ptc2 and GST-Ptc2 (1-312)-kinase-dead, respectively. GST proteins were expressed in the BL21 (DE3) pLysS strain in LB plus Amp and induced with 1 mM isopropyl-1-thio-β-D-galactopyranoside (IPTG) at 37°C for 3 hr. The GST-tagged proteins were purified with Glutathione Sepharose 4B (GE) in binding buffer (140 mM NaCl, 2.7 mM KCl, 10 mM Na~2~HPO4, 1.8 mM KH~2~PO4 pH 7.5, 1% Triton X-100, 10% glycerol) for 1 hr and eluted with elution buffer (50 mM Tris-HCl, 10 mM reduced glutathione pH 8.0).

The kinase assay was started by mixing different sources of PKA (50 mM extracts from KT1115) with GST-Ids2 substrates in kinase buffer (50 mM potassium phosphate pH 7.5, 0.1 mM EGTA, 0.1 mM EDTA, 15 mM MgCl~2~, 10 mM β-mercaptoethanol, 100 mM ATP). After 15 min at 30°C, the samples were analyzed by Western blotting with Ids2 S148 phosphospecific antibodies. For the isotope assay, additional γ-^32^P-ATP was added to the mixture, and the aliquots were processed according to the phosphocellulose paper method ([@bib55]).

For the phosphatase assay, phosphorylated Ids2 was generated by incubating GST-Ids2 with bovine heart catalytic subunit C (C~b~) in kinase buffer for 15 min at 30°C. The reaction was stopped by incubating with PKI 6--22 at 30°C for 10 min. GST-Ptc2 or GST-Ptc2 (1-312) was then added to the mixture for the phosphatase reaction. After 15 min at 30°C, samples were analyzed by Western blotting with Ids2 S148 phosphospecific antibodies.

Co-immunoprecipitation assay {#s4-11}
----------------------------

W303 strains containing chromosomally-tagged *HSC82*-HA~3~ and *IDS2* plasmids (pRS426-*IDS2*-Myc~13~, pRS426-*ids2-S148A*-Myc~13~, or pRS426-*ids2-S148D*-Myc~13~) were grown to exponential phase, and cells were harvested. Pellets were resuspended in lysis buffer (50 mM NaCl, 0.1 % NP-40, 150 mM Tris-HCl pH 8.0) supplemented with protease inhibitors (Roche). Cells were broken by a *FastPrep*-24 5G Homogenizer (MP biomedical) and supernatants were collected after centrifugation. The supernatants were mixed with either anti-HA (Roche) or anti-Myc (Roche) antibodies, and followed by incubation with protein G Sepharose beads. Immunoprecipitates were washed four times with lysis buffer and then eluted by boiling in sample buffer. Samples were resolved by 7% SDS-PAGE and analyzed by Western blotting using the appropriate antibodies.

Yeast Two-hybrid analysis {#s4-12}
-------------------------

To investigate the interaction between Ids2 and Hsc82, a DNA fragment encoding the full length or N-terminal amino acids of Ids2 was ligated downstream of the Gal4 DNA-binding domain in pGBDU-C1. A fragment encoding the full length or N-terminal amino acids of Hsc82 was inserted in pGAD-C1 downstream of the Gal4 DNA-activating domain. The resulting plasmids were transformed into PJ69-4A and Leu^+^ and Ura^+^ cells were selected. Cells were restreaked on SC-Leu-Ure-Ade-His glucose plates to inspect the bait-prey reciprocity.

His-tagged metal affinity purification assay {#s4-13}
--------------------------------------------

An expression construct bearing Hsc82 with an N-terminal His~6~-tag was transformed into *E. coli. E. coli* cultures were grown in LB media to an OD~600~ of 0.8 and then induced with 0.5 mM IPTG for 4 hr. The His**~6~**-tag proteins were purified with TALON His-tagged Protein Purification Resins (GE) in binding buffer (50 mM Tris-HCl pH 8.0, 100 mM NaCl, 50 mM imidazole, 1% Triton X-100) for 1 hr and eluted with elution buffer (50 mM Tris-HCl pH 8.0, 250 mM imidazole, 10% glycerol).

For the His~6~-Hsc82 pull-down assay, purified His~6~-Hsc82 were incubated with purified GST-Ids2 or GST-Ids2-S148D in incubation buffer (20 mM Tris-HCl pH 7.5, 50 mM NaCl, 5% glycerol, 0.01% Triton X-100, 2 mM DTT) at 4°C for 1 hr. The reaction was precipitated with TALON His-tagged Protein Purification Resins (GE) at 4°C for 1 hr. After washing three times with incubation buffer, the His~6~-tagged Hsc82 and co-purified Ids2 proteins were recovered by elution with imidazole.

ATPase assay {#s4-14}
------------

For the ATPase assay, His~6~-Hsc82, GST-Ids2, and GST-Ids2-S148D proteins were isolated on appropriate columns (a HisTrap FF column for His-tagged proteins and a GSTrap FF column for GST-tagged proteins) using AKTA Explorer FPLC (GE Healthcare) and further purified by size exclusion chromatography on a Superdex 200 column (GE healthcare) in 25 mM Hepes pH 7.2, 50 mM NaCl, and 5 mM β-mercaptoethanol.

The ATPase activity of Hsc82 was measured by using EnzChek phosphate assay kit (Molecular Probes, Inc.) as previously described ([@bib65]). The His~6~-Hsc82 protein (2 μM) was incubated with Ids2 or Ids2-S148D protein at 37°C with 1 mM ATPase buffer (40 mM HEPES pH 7.5, 150 mM KCl, 5 mM MgCl~2~, 2 mM DTT). The reactions were incubated for 90 min and then diluted 1:5 into a 100 μl phosphate assay reaction as outlined by the manufacturer\'s instructions. A standard curve was generated using the inorganic phosphate solution provided by the manufacturer (Molecular Probes, Inc.).

In Vivo chaperone assay {#s4-15}
-----------------------

For the luciferase assay, a pRS316 plasmid containing the *GAL1-10* promoter and the SEL-allele of firefly luciferase ([@bib12]) was purchased from Addgene and transformed into wild-type, *ids2Δ*, *hsc82Δ, ids2-S148A,* and *ids2-S148D* cells. Cells were inoculated into raffinose medium and cultured overnight prior to 3 hr galactose induction in 25°C temperatures. Then, the culture aliquoted and transferred to an incubator at 30°C and 37°C temperature, respectively. After 2 hr incubation, the protein was precipitated by TCA and Western blot analysis was performed with anti-firefly luciferase antibodies (Genetex).

The GR maturation assay was performed as previously described ([@bib68]). In brief, pG/N795 (Addgene) encoding mammalian steroid receptor GR and pUCΔSS-26X (Addgene) encoding the β-galactosidase reporter were transformed into wild-type, *ids2Δ*, *hsc82Δ, ids2-S148A,* and *ids2-S148D* cells. Each strain from the overnight culture was diluted to 0.4 OD~600~ in fresh media containing 10 μM synthetic hormone analog deoxycorticosterone (Sigma). After 5 hr incubation, the cells were harvested and the β-galactosidase activity was measured.

For the v-Src toxicity assay, cells were transformed with plasmids containing either v-Src or c-Src in pY413 ([@bib5]). After stationary phase growth in glucose-containing selection medium, 3 μl aliquots from the serial dilutions were spotted on plates containing galactose and raffinose.

Induction of Gln1 foci by glucose deprivation {#s4-16}
---------------------------------------------

Cells with Gln1-GFP expression were inoculated into fresh SC glucose selection medium to 0.3 OD/ml from an overnight culture. When cells were regrown to 1 OD/ml, cells were washed with PBS and then resuspended in SC medium without glucose for 45 min to induce foci formation. After induction, cells were harvested and fixed with 3.7% formaldehyde. Statistical significance was analyzed by the student's t-test using GraphPad Prism 5 (GraphPad Software, Inc.). The amount of *GLN1* and *ACT1* mRNA was quantified by real-time reverse transcription polymerase chain reaction (RT-PCR) (Kappa), using primers listed in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Glucose intake hampers PKA-regulated HSP90 chaperone activity\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Philip Cole as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Overall, the data in this paper position Ids2 as a previously unknown target of a phosphorylation switch and as a modulator of cellular stress, lifespan, and potentially as a regulator of Hsp90. These are important findings. However, the authors claim that these data highlight a previously unknown link between CR/lifespan and proteostasis is not supported, and this conclusion needs to be softened. In addition, direct effects of this putative co-chaperone on Hsp90 function, using established cell-based and in vitro assays, is essential to support the role of this factor on Hsp90 activity. In turn, the fact that Ids2 was reported as a DNA binding factor suggests instead that it might act with Hsp90 via the established role of Hsp90 and select co-chaperones as a regulator of transcription. This might explain changes in luciferase expression and Gln1-GFP aggregates presented and should be discussed.

The authors should make clear one major caveat of the initial phosphoproteomics data -- that it is not normalized to changes in total protein levels upon caloric restriction. Therefore, it is not possible to differentiate between the phospopeptides that are changed due to a change in the abundance of the protein itself from those that are actually changed due to phosphorylation/desphosphorylation events.

The control for the Ids2-TAP IP-MS experiment is not ideal. A better control would be cells expressing just the TAP tag alone (Protein A + CBP), to discount non-specific hits that bind either of these two proteins. This is especially important given that Hsc82/Hsp82 are common contaminants in affinity proteomics experiments (as defined by the CRAPome database).

Finally, the authors suggest that this Ids2-dependent regulation of Hsc90 activity is key to longevity control, allows survival during chronological aging (starvation in stationary phase), and is required for CR to retard aging in stationary phase (it is stated, for example, that \"PP2C phosphatase antagonizes the function of PKA to extend lifespan\"). In this respect, the data does not at present support these conclusions and more data is required for making this link. For example, the authors should test whether Ids2 and Hsc90 are required for CR to prolong lifespan -- no CR experiments are included presently. Also, for the conclusions stated it is expected that the *ids2-S148A* mutant should display a longer lifespan even without CR -- is this true and if so, does it depend on Hsc90?

10.7554/eLife.39925.024

Author response

> Overall, the data in this paper position Ids2 as a previously unknown target of a phosphorylation switch and as a modulator of cellular stress, lifespan, and potentially as a regulator of Hsp90. These are important findings. However, the authors claim that these data highlight a previously unknown link between CR/lifespan and proteostasis is not supported, and this conclusion needs to be softened. In addition, direct effects of this putative co-chaperone on Hsp90 function, using established cell-based and in vitro assays, is essential to support the role of this factor on Hsp90 activity. In turn, the fact that Ids2 was reported as a DNA binding factor suggests instead that it might act with Hsp90 via the established role of Hsp90 and select co-chaperones as a regulator of transcription. This might explain changes in luciferase expression and Gln1-GFP aggregates presented and should be discussed.

As suggested by the reviewers, we have softened our statements in Abstract, in Figure 5 legend, and in other places. To investigate the putative co-chaperone function on HSP90, the glucocorticoid receptor (GR) activity (Schena and Yamamoto, 1988) and v-Src toxicity (Boczek et al., 2015) assays have been performed. For monitoring GR maturation, the strains were co-transformed with a plasmid that constitutively expresses GR and a plasmid carrying a β-galactosidase reporter. We observed that the GR activity in the *ids2Δ* and its phosphomimetic mutant, *ids2-S148D,* decreased compared with that in the wild-type cells (new Figure 4---figure supplement 2A). Consistently, the v-Src toxicity, which is strictly dependent on yeast HSP90 in vivo, reduced in the *ids2D* and *ids2-S148D* strains (new Figure 4---figure supplement 2B). The results support our model that Ids2 may serve as a co-chaperone orchestrating the HSP90 function.

Although a potential DNA binding ability of Ids2 might have a chance to affect our luciferase expression and the Gln1-GFP aggregation results through transcriptional activation, in our firefly luciferase experiment, we expressed firefly luciferase under a *GAL1* promoter. The control samples were first grown at 25 °C and then shifted to higher temperatures (30 °C and 37 °C). There was no apparent decrease in firefly luciferase protein levels in *ids2Δ, hsc82Δ*, and *ids2-S148D* cells compared to that in the wild-type strain when we induced the expression with galactose at 25 °C (Figure 4C). Therefore, the reduction of the firefly luciferase protein under the higher temperature is probably not through an Ids2-mediated transcriptional activation on the *GAL1* promoter, but most likely due to protein degradation of misfolded firefly luciferase as Professor Susan Lindquist previously suggested (Nathan et al., 1997). Moreover, in the Gln1-GFP aggregation experiment, we have further examined the *GLN1* mRNA expression in the tested strains under glucose starvation using real-time quantitative reverse transcription PCR (new Figure 4D). The transcriptional level of *GLN1* did not show any significant change in these strains, indicating that the appearance of Gln1-GFP aggregates was not a consequence of the difference of transcriptional regulation of Ids2 on *GLN1*.

> The authors should make clear one major caveat of the initial phosphoproteomics data -- that it is not normalized to changes in total protein levels upon caloric restriction. Therefore, it is not possible to differentiate between the phospopeptides that are changed due to a change in the abundance of the protein itself from those that are actually changed due to phosphorylation/desphosphorylation events.

For the phosphoproteomic analysis used in this study, indeed we cannot rule out the possibility that the phosphopeptides were changed due to a change in the abundance of the protein itself. As suggested by the reviewer, we have added this possibility in Discussion (first paragraph). Moreover, to minimize this vagueness, we have marked the proteins (n = 16) in red in our mass data (new Figure 1---source data 1) that have been reported to be influenced on the transcriptional levels under CR stress according to a previous research (Lee and Lee, 2008). For the only positive candidate Ids2, we have verified that the protein level of Ids2 is not a major issue of regulation under CR (new Figure 2---figure supplement 1B).

> The control for the Ids2-TAP IP-MS experiment is not ideal. A better control would be cells expressing just the TAP tag alone (Protein A + CBP), to discount non-specific hits that bind either of these two proteins. This is especially important given that Hsc82/Hsp82 are common contaminants in affinity proteomics experiments (as defined by the CRAPome database).

As suggested by the reviewer, we have added the cells expressing the TAP tag alone as a control (new Figure 3---figure supplement 1). We have used an HSP90 specific antibody to confirm that the signal was faithfully derived from HSP90 (Hsc82/Hsp82) protein and only appeared in the Ids2-TAP-pulldown, but not in the TAP-alone pulldown. The results indicate that the signal around 80 kDa on the silver staining gel may mainly come from the HSP90 proteins.

> Finally, the authors suggest that this Ids2-dependent regulation of Hsc90 activity is key to longevity control, allows survival during chronological aging (starvation in stationary phase), and is required for CR to retard aging in stationary phase (it is stated, for example, that \"PP2C phosphatase antagonizes the function of PKA to extend lifespan\"). In this respect, the data does not at present support these conclusions and more data is required for making this link. For example, the authors should test whether Ids2 and Hsc90 are required for CR to prolong lifespan -- no CR experiments are included presently. Also, for the conclusions stated it is expected that the ids2-S148A mutant should display a longer lifespan even without CR -- is this true and if so, does it depend on Hsc90?

To test whether Ids2 and Hsc82 are required for CR-mediated lifespan extension, we have measured the chronological lifespan of *ids2Δ, hsc82Δ*, *ids2-S148A* and *ids2-S148D* under CR (0.5% glucose). Indeed, *ids2Δ, hsc82Δ*, and *ids2-S148D* strains lost their ability to extend lifespan under CR, and the *ids2-S148A* mutant showed lifespan extension as the wild-type control under CR (new Figure 4---figure supplement 2C). Moreover, the *ids2-S148A* mutant did not display a longer lifespan than the wild-type strain under normal condition. Based on these findings, we speculate that HSP90 needs dephosphorylated Ids2 for its full chaperone complex activity to extend lifespan under normal and CR conditions, and in yeast Ids2 may provide enough dephosphorylated form under normal condition for HSP90's activity. We have softened our model (Introduction, first paragraph and Figure 5 legend, and other places) based on these observations.
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